Mauna Kea Technologies SAS (ALMKT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.077x

Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has a cash flow conversion efficiency ratio of 0.077x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.28 Million ≈ $-2.67 Million USD) by net assets (€-29.42 Million ≈ $-34.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Mauna Kea Technologies SAS - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Mauna Kea Technologies SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Mauna Kea Technologies SAS for a breakdown of total debt and financial obligations.

Mauna Kea Technologies SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mauna Kea Technologies SAS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kincora Copper Ltd
AU:KCC
-0.005x
ContextVision AB
OL:CONTX
-0.022x
Chien Wei Precise Technology Co Ltd
TWO:8092
0.096x
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
0.033x
C-Com Satellite Systems Inc.
V:CMI
0.006x
Okong Corporation
KQ:045060
0.044x
TOUAX
PA:ALTOU
-0.167x
Desoto Resources Ltd
AU:DES
-0.155x

Annual Cash Flow Conversion Efficiency for Mauna Kea Technologies SAS (2010–2024)

The table below shows the annual cash flow conversion efficiency of Mauna Kea Technologies SAS from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Mauna Kea Technologies SAS (ALMKT) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-24.39 Million
≈ $-28.51 Million
€-6.32 Million
≈ $-7.39 Million
0.259x +494.90%
2023-12-31 €-17.28 Million
≈ $-20.20 Million
€-753.00K
≈ $-880.34K
0.044x -90.16%
2022-12-31 €-19.93 Million
≈ $-23.29 Million
€-8.83 Million
≈ $-10.32 Million
0.443x -55.43%
2021-12-31 €-10.33 Million
≈ $-12.08 Million
€-10.27 Million
≈ $-12.01 Million
0.994x +50.29%
2020-12-31 €-12.08 Million
≈ $-14.12 Million
€-7.99 Million
≈ $-9.34 Million
0.662x +101.63%
2019-12-31 €253.00K
≈ $295.78K
€-10.27 Million
≈ $-12.01 Million
-40.601x -2872.05%
2018-12-31 €7.98 Million
≈ $9.33 Million
€-10.90 Million
≈ $-12.74 Million
-1.366x -134.80%
2017-12-31 €16.74 Million
≈ $19.58 Million
€-9.74 Million
≈ $-11.39 Million
-0.582x +17.16%
2016-12-31 €11.16 Million
≈ $13.04 Million
€-7.84 Million
≈ $-9.16 Million
-0.702x +15.62%
2015-12-31 €14.09 Million
≈ $16.47 Million
€-11.73 Million
≈ $-13.71 Million
-0.832x -18.67%
2014-12-31 €18.15 Million
≈ $21.22 Million
€-12.73 Million
≈ $-14.88 Million
-0.701x -120.08%
2013-12-31 €30.16 Million
≈ $35.26 Million
€-9.61 Million
≈ $-11.24 Million
-0.319x +3.61%
2012-12-31 €40.16 Million
≈ $46.95 Million
€-13.28 Million
≈ $-15.53 Million
-0.331x -176.02%
2011-12-31 €51.57 Million
≈ $60.30 Million
€-6.18 Million
≈ $-7.22 Million
-0.120x +67.12%
2010-12-31 €6.86 Million
≈ $8.02 Million
€-2.50 Million
≈ $-2.92 Million
-0.364x --

About Mauna Kea Technologies SAS

PA:ALMKT France Medical Devices
Market Cap
$41.32 Million
€35.35 Million EUR
Market Cap Rank
#23875 Global
#387 in France
Share Price
€0.18
Change (1 day)
+0.11%
52-Week Range
€0.07 - €0.22
All Time High
€5.37
About

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more